{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-03-01&answer.answeringMemberConstituency=Winchester", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2019-03-01&answer.answeringMemberConstituency=Winchester", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-03-01&answer.answeringMemberConstituency=Winchester&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-03-01&_page=0&answer.answeringMemberConstituency=Winchester", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-03-01&answer.answeringMemberConstituency=Winchester", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-03-01&answer.answeringMemberConstituency=Winchester", "items" : [{"_about" : "http://data.parliament.uk/resources/1079576", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1079576/answer", "answerText" : {"_value" : "<p>Ultraviolet (UV) radiation-emitting tanning devices, including sunbeds, were classified in 2009 as \u2018carcinogenic to humans\u2019 by the International Agency for Research on Cancer based on consistent evidence of a positive association between their use and incidence of melanoma.<\/p><p> <\/p><p>In 2009, the Committee on Medical Aspects of Radiation in the Environment published advice to United Kingdom Government on the health effects and risks from UV sunbeds and concluded that there is evidence to suggest an increased risk of skin cancer among those who use sunbeds before the age of 35. The Committee's Report is available at the following link:<\/p><p> <\/p><p><a href=\"https://www.gov.uk/government/publications/comare-13th-report\" target=\"_blank\">https://www.gov.uk/government/publications/comare-13th-report<\/a><\/p><p> <\/p><p>The World Health Organization (WHO) report on \u2018Artificial tanning devices: public health interventions to manage sunbeds\u2019 states that melanoma risk increases with younger age of first sunbed use and with greater lifetime use of sunbeds. The WHO report can be viewed at the following link:<\/p><p> <\/p><p><a href=\"https://www.who.int/uv/publications/artificial-tanning-devices/en/\" target=\"_blank\">https://www.who.int/uv/publications/artificial-tanning-devices/en/<\/a><\/p><p> <\/p><p>A systematic review in the British Medical Journal (BMJ) showed that people who have used a sunbed at least once at any stage in their life have a 20% higher risk of developing melanoma than people who have never used a sunbed, and the first use of sunbeds before the age of 35 increases the risk of developing melanoma by 59%. The BMJ report can be viewed at the following link:<\/p><p> <\/p><p><a href=\"https://www.bmj.com/content/345/bmj.e4757.long\" target=\"_blank\">https://www.bmj.com/content/345/bmj.e4757.long<\/a><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-06", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-06T16:37:32.703Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Skin Cancer: Sunbeds"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential correlation between the use of sunbeds for tanning the risk of skin cancer; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4672", "label" : {"_value" : "Biography information for Ged Killen"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rutherglen and Hamilton West"}
      , "tablingMemberPrinted" : [{"_value" : "Ged Killen"}
      ], "uin" : "227416"}
    , {"_about" : "http://data.parliament.uk/resources/1079577", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1079577/answer", "answerText" : {"_value" : "<p>The information requested is not held in the format requested.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-06", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-06T11:03:16.813Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cancer: Radiotherapy"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, the proportion of cancer patients in England received radiotherapy as part of their primary treatment in 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1591", "label" : {"_value" : "Biography information for Tim Farron"}
      }
      , "tablingMemberConstituency" : {"_value" : "Westmorland and Lonsdale"}
      , "tablingMemberPrinted" : [{"_value" : "Tim Farron"}
      ], "uin" : "227381"}
    , {"_about" : "http://data.parliament.uk/resources/1079586", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1079586/answer", "answerText" : {"_value" : "<p>Updating cost estimates of alcohol harm is complex because circumstances, prevalence and treatments may have changed. The Department is exploring the possibility and feasibility of carrying out research to update the cost estimates that are currently available.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-07", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-07T16:31:21.3Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Alcoholic Drinks: Misuse"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 February 2019 to Question 224315, for what reasons his Department has not made a recent estimate based on up to date prices of the cost to the NHS of treating injuries caused by excessive alcohol consumption.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1566", "label" : {"_value" : "Biography information for Daniel Kawczynski"}
      }
      , "tablingMemberConstituency" : {"_value" : "Shrewsbury and Atcham"}
      , "tablingMemberPrinted" : [{"_value" : "Daniel Kawczynski"}
      ], "uin" : "227380"}
    , {"_about" : "http://data.parliament.uk/resources/1079588", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1079588/answer", "answerText" : {"_value" : "<p>In 2017/18 a formal procurement process was undertaken by NHS England for approximately half of the PET/CT scanning services in England including the service provided to the population of the Thames Valley area. The evaluation criteria included clinical/service quality, patient access and cost. The preferred bidder InHealth submitted a bid which satisfied all the necessary criteria and achieved the highest score.<\/p><p>Patient access, quality and cost were included in the evaluation criteria. There are discussions currently in progress with both InHealth and Oxford University Hospitals about mobilising the new service. There are also discussions with the hospitals in Milton Keynes and Swindon about the start-up of their new services.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-06", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "227414"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-06T16:32:09.897Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Tomography: Oxfordshire"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, for what reasons the contract for PET-CT scanning in Oxfordshire was awarded to InHealth and not Oxford University Hospitals Trust.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4656", "label" : {"_value" : "Biography information for Layla Moran"}
      }
      , "tablingMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
      , "tablingMemberPrinted" : [{"_value" : "Layla Moran"}
      ], "uin" : "227413"}
    , {"_about" : "http://data.parliament.uk/resources/1079589", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1079589/answer", "answerText" : {"_value" : "<p>In 2017/18 a formal procurement process was undertaken by NHS England for approximately half of the PET/CT scanning services in England including the service provided to the population of the Thames Valley area. The evaluation criteria included clinical/service quality, patient access and cost. The preferred bidder InHealth submitted a bid which satisfied all the necessary criteria and achieved the highest score.<\/p><p>Patient access, quality and cost were included in the evaluation criteria. There are discussions currently in progress with both InHealth and Oxford University Hospitals about mobilising the new service. There are also discussions with the hospitals in Milton Keynes and Swindon about the start-up of their new services.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-06", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "227413"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-06T16:32:09.963Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Tomography: Inhealthcare"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect on (a) accessibility, (b) cost and (c) quality of care of moving the PET-CT scanning service from Churchill Hospital in Oxford as a result of the decision to award the contract for scanning to InHealth.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4656", "label" : {"_value" : "Biography information for Layla Moran"}
      }
      , "tablingMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
      , "tablingMemberPrinted" : [{"_value" : "Layla Moran"}
      ], "uin" : "227414"}
    , {"_about" : "http://data.parliament.uk/resources/1079601", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1079601/answer", "answerText" : {"_value" : "<p>On 30 January, my Rt. hon. Friend the Secretary of State for Health and Social Care announced that the Pre-exposure Prophylaxis (PrEP) Impact trial would be expanded to 26,000 people. Rollout of additional places on the trial is now commencing and will be an important element in our HIV prevention efforts.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-07", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-07T16:32:32.227Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "HIV Infection: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 February to Question 222647 on HIV: Infection, what the timetable is for the review of the number of places available on the Pre-exposure Prophylaxis Impact trial by the PrEP Oversight Board.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4615", "label" : {"_value" : "Biography information for Lloyd Russell-Moyle"}
      }
      , "tablingMemberConstituency" : {"_value" : "Brighton, Kemptown"}
      , "tablingMemberPrinted" : [{"_value" : "Lloyd Russell-Moyle"}
      ], "uin" : "227401"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}